We are live on ! Find out more
IART icon

Integra LifeSciences
IART

261 hedge funds and large institutions have $5.26B invested in Integra LifeSciences in 2021 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 101 increasing their positions, 75 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more repeat investments, than reductions

Existing positions increased: 101 | Existing positions reduced: 75

2.46% more ownership

Funds ownership: 88.46% → 90.91% (+2.5%)

3% more capital invested

Capital invested by funds: $5.09B → $5.26B (+$167M)

2% more call options, than puts

Call options by funds: $17.2M | Put options by funds: $16.8M

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 30

1% less funds holding

Funds holding: 264 → 261 (-3)

Holders
261
Holders Change
-3
Holders Change %
-1.14%
% of All Funds
4.57%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
30
Increased
101
Reduced
75
Closed
30
Calls
$17.2M
Puts
$16.8M
Net Calls
+$377K
Net Calls Change
-$1.33M

Top Buyers

1
AllianceBernstein
AllianceBernstein
Tennessee
+$140M
2
EVM
Eaton Vance Management
Massachusetts
+$75M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$25.7M
4
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
California
+$20.8M
5
Morgan Stanley
Morgan Stanley
New York
+$14.4M

Top Sellers

1
CIP
Champlain Investment Partners
Vermont
-$55.3M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$35.3M
3
CB
Cooke & Bieler
Pennsylvania
-$26.1M
4
Norges Bank
Norges Bank
Norway
-$17.2M
5
Jennison Associates
Jennison Associates
New York
-$12.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
N
151
Natixis
France
$551K -$323K -4,570 -36%
US Bancorp
152
US Bancorp
Minnesota
$539K -$848 -12 -0.2%
Brown Advisory
153
Brown Advisory
Maryland
$522K -$183K -2,587 -25%
Osaic Holdings
154
Osaic Holdings
Arizona
$506K +$12.4K +175 +2%
TRCT
155
Tower Research Capital (TRC)
New York
$500K +$106K +1,498 +26%
Pacer Advisors
156
Pacer Advisors
Pennsylvania
$499K -$12.7K -180 -2%
ZB
157
Zions Bancorporation
Utah
$499K +$56.2K +795 +12%
LWM
158
Loveless Wealth Management
Montana
$498K – – –
IMRF
159
Illinois Municipal Retirement Fund
Illinois
$494K – – –
MC
160
Maverick Capital
Texas
$480K -$1.08M -15,292 -69%
Zurich Cantonal Bank
161
Zurich Cantonal Bank
Switzerland
$478K – – –
SF
162
Synovus Financial
Georgia
$466K -$218K -3,087 -31%
ProShare Advisors
163
ProShare Advisors
Maryland
$462K -$83.9K -1,188 -15%
CGH
164
Crossmark Global Holdings
Texas
$447K +$1.41K +20 +0.3%
SAM
165
Securian Asset Management
Minnesota
$446K – – –
Deutsche Bank
166
Deutsche Bank
Germany
$437K +$16.6K +235 +4%
JMPWA
167
JP Morgan Private Wealth Advisors
California
$402K +$29.6K +419 +8%
MSRPS
168
Maryland State Retirement & Pension System
Maryland
$386K – – –
Janney Montgomery Scott
169
Janney Montgomery Scott
Pennsylvania
$383K – – –
VPIM
170
Vanguard Personalized Indexing Management
California
$382K +$395K +5,585 New
VIM
171
Vista Investment Management
Pennsylvania
$377K – – –
CCP
172
Corient Capital Partners
California
$359K +$7.14K +101 +2%
FMT
173
First Mercantile Trust
Tennessee
$359K +$175K +2,483 +90%
BAM
174
Burgundy Asset Management
Ontario, Canada
$357K – – –
QCM
175
Quantinno Capital Management
New York
$354K +$6.22K +88 +2%
5 6
7
8 9

IART Hedge Fund Activity: Q3 2021 in Review

261 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q3 2021, worth a combined $5.26B — up 3.3% from $5.09B a quarter earlier.

Fund positioning in IART was balanced in Q3 2021: 30 funds opened new positions, 30 closed out, 101 added to existing stakes and 75 trimmed.

The largest buyer was AllianceBernstein, adding an estimated $140M. The largest seller was Champlain Investment Partners, cutting an estimated $55.3M.

  • 261 institutional investors held Integra LifeSciences (IART) as of Q3 2021, down from 264 in Q2 2021.
  • Funds reported $5.26B of Integra LifeSciences stock for Q3 2021, up 3.3% quarter-over-quarter.
  • 30 funds opened new Integra LifeSciences positions in Q3 2021 and 30 closed out, a net change of 0 holders.
  • The largest Integra LifeSciences buyer in Q3 2021 was AllianceBernstein, an estimated $140M added.
  • The largest Integra LifeSciences seller in Q3 2021 was Champlain Investment Partners, an estimated $55.3M sold.

Based on aggregated 13F filings for Q3 2021.